Lulu Hui
- Molecular Biology
- Cancer Research top 5%
- Oncology
- Pathology and Forensic Medicine
- Complementary and alternative medicine
- Topics
- MicroRNA in disease regulation (6 papers)Natural Compounds in Disease Treatment (3 papers)RNA modifications and cancer (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Lulu Hui
9 papers receiving 568 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 450
- Cancer Research 397
- Oncology 76
- Pathology and Forensic Medicine 31
- Complementary and alternative medicine 30
Countries citing papers authored by Lulu Hui
This map shows the geographic impact of Lulu Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lulu Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lulu Hui more than expected).
Fields of papers citing papers by Lulu Hui
This network shows the impact of papers produced by Lulu Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lulu Hui. The network helps show where Lulu Hui may publish in the future.
Co-authorship network of co-authors of Lulu Hui
This figure shows the co-authorship network connecting the top 25 collaborators of Lulu Hui. A scholar is included among the top collaborators of Lulu Hui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lulu Hui. Lulu Hui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 137 | |
| 2 | 26 | |
| 3 | 53 | |
| 4 | 48 | |
| 5 | 28 | |
| 6 | 152 | |
| 7 | 105 | |
| 8 | [Effect of triptolide on sensitivity of K562/A02 cell line to adriamycin]. | 1 |
| 9 | 23 |
About Lulu Hui
Lulu Hui is a scholar working on Cancer Research, Complementary and alternative medicine and Molecular Biology, having authored 9 papers that have together received 573 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Natural Compounds in Disease Treatment (3 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (397 citations), Molecular Biology (450 citations) and Complementary and alternative medicine (30 citations). Lulu Hui has collaborated with scholars based in China and United States. Frequent co-authors include Wenlin Xu, Huiling Shen, Xiaolan Zhu, Lulu Long, Yuefeng Li, Hao Li, Hao Li, Hao Li, Hai‐Ning Chen and Xuefeng Wang. Their work appears in journals such as Oncogene, FEBS Letters and Pharmaceutical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.